| $385M | ||
| $350M | ||
| $215M | ||
| $88M | ||
| $82M | ||
| $62M |
Buys | $469,994 | 4 | 100 |
Sells | $0 | 0 | 0 |
| KERSTEN GEERT R | Chief Executive Officer | 3 | $449,999 | 0 | $0 | $449,999 |
| Watson Robert Eugene | director | 1 | $19,995 | 0 | $0 | $19,995 |
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
Over the last 12 months, insiders at CEL-SCI Corporation have bought $469,994 and sold $0 worth of CEL-SCI Corporation stock.
On average, over the past 5 years, insiders at CEL-SCI Corporation have bought $269,528 and sold $412,543 worth of stock each year.
Highest buying activity among insiders over the last 12 months: KERSTEN GEERT R (Chief Executive Officer) — $449,999. Watson Robert Eugene (director) — $19,995.
The last purchase of 38,023 shares for transaction amount of $200,001 was made by KERSTEN GEERT R (Chief Executive Officer) on 2026‑01‑22.
| 2026-01-22 | KERSTEN GEERT R | Chief Executive Officer | 38,023 0.4598% | $5.26 | $200,001 | -18.41% | ||
| 2025-12-04 | KERSTEN GEERT R | Chief Executive Officer | 8,389 0.1164% | $5.96 | $49,998 | -16.38% | ||
| 2025-07-25 | KERSTEN GEERT R | Chief Executive Officer | 29,197 0.3576% | $6.85 | $199,999 | -13.54% | ||
| 2025-07-25 | Watson Robert Eugene | director | 2,919 0.0357% | $6.85 | $19,995 | -13.54% | ||
| 2024-05-08 | KERSTEN GEERT R | Chief Executive Officer | 30,000 0.0556% | $1.39 | $41,700 | -43.53% | ||
| 2024-05-08 | PRICHEP PATRICIA B | Senior Vice President | 8,000 0.0148% | $1.39 | $11,120 | -43.53% | ||
| 2024-05-08 | Watson Robert Eugene | director | 20,000 0.0371% | $1.39 | $27,800 | -43.53% | ||
| 2021-10-19 | Sale | TALOR EYAL | Chief Scientific Officer | 15,000 0.0345% | $11.25 | $168,750 | -63.02% | |
| 2021-07-06 | KERSTEN GEERT R | Chief Executive Officer | 25,000 0.0615% | $8.00 | $200,000 | -9.69% | ||
| 2021-07-06 | BAILLAVOINE BRUNO JEAN-MARIE | director | 1,250 0.0031% | $8.00 | $10,000 | -9.69% | ||
| 2021-07-06 | Watson Robert Eugene | director | 1,250 0.0031% | $8.00 | $10,000 | -9.69% | ||
| 2021-06-28 | YOUNG PETER R | director | 3,000 0.0068% | $12.66 | $37,971 | -44.12% | ||
| 2021-04-22 | Sale | CIPRIANO JOHN | Senior Vice President | 10,000 0.0244% | $24.38 | $243,793 | -62.09% | |
| 2020-12-11 | YOUNG PETER R | director | 100 0.0003% | $14.24 | $1,424 | -8.02% | ||
| 2020-11-18 | BAILLAVOINE BRUNO JEAN-MARIE | director | 800 0.0021% | $11.77 | $9,416 | +16.45% | ||
| 2020-11-18 | Watson Robert Eugene | director | 800 0.0021% | $11.77 | $9,416 | +16.45% | ||
| 2020-11-17 | YOUNG PETER R | director | 800 0.0021% | $11.68 | $9,343 | +16.15% | ||
| 2020-11-13 | Sale | CIPRIANO JOHN | Senior Vice President | 10,000 0.026% | $12.73 | $127,290 | +6.47% | |
| 2020-11-04 | YOUNG PETER R | director | 3,000 0.0076% | $11.35 | $34,060 | +16.45% | ||
| 2020-02-26 | KERSTEN GEERT R | Chief Executive Officer | 4,617 0.0128% | $10.83 | $50,002 | +23.45% |
| KERSTEN GEERT R | Chief Executive Officer | 120815 1.7582% | $552,124.55 | 33 | 0 | +24.9% |
| Watson Robert Eugene | director | 3733 0.0543% | $17,059.81 | 5 | 0 | <0.0001% |
| KINSOLVING C RICHARD | director | 302247 4.3985% | $1.38M | 0 | 4 | |
| DE CLARA MAXIMILIAN | President | 251234 3.6561% | $1.15M | 0 | 67 | |
| PRICHEP PATRICIA B | Senior Vice President | 232326 3.381% | $1.06M | 7 | 0 | <0.0001% |
| ZIMMERMAN DANIEL H | Senior Vice President | 114387 1.6646% | $522,748.59 | 5 | 3 | +23.45% |
| TALOR EYAL | Chief Scientific Officer | 104899 1.5266% | $479,388.43 | 4 | 16 | |
| CIPRIANO JOHN | Senior Vice President | 63108 0.9184% | $288,403.56 | 3 | 5 | |
| YOUNG PETER R | director | 28914 0.4208% | $132,136.98 | 13 | 2 | +35.12% |
| BAILLAVOINE BRUNO JEAN-MARIE | director | 5973 0.0869% | $27,296.61 | 3 | 0 | +10.07% |
| ESTERHAZY ALEXANDER G | director | 0 0% | $0 | 0 | 8 |
$14,315,062 | 61 | -6.21% | $30.29M | |
$94,610,184 | 33 | -23.48% | $28.02M | |
$38,601,028 | 29 | 1.18% | $28.77M | |
CEL-SCI Corporation (CVM) | $711,440 | 26 | 20.43% | $31.4M |
$523,320 | 24 | 94.37% | $34.55M | |
$241,165 | 22 | -16.72% | $33.54M | |
$7,733,516 | 17 | 73.42% | $32.37M | |
$91,209,456 | 15 | -7.00% | $31.97M | |
$1,091,554 | 14 | -16.96% | $31.11M | |
$145,194 | 11 | -27.37% | $35.74M | |
$33,809,329 | 11 | -64.88% | $28.97M | |
$70,584,874 | 10 | 3.97% | $29.53M | |
$232,423 | 8 | 14.22% | $35.92M | |
$8,470,804 | 6 | -13.28% | $30.79M | |
$49,127 | 3 | -42.90% | $35.37M | |
$100,266 | 2 | 3.17% | $29.2M | |
$8,997,728 | 2 | -11.16% | $33.8M | |
$150,000 | 1 | 5.48% | $31.09M | |
$5,512,500 | 1 | -7.91% | $34.6M |
| Increased Positions | 18 | +45% | 118,436 | +13.8% |
| Decreased Positions | 14 | -35% | 262,794 | -30.61% |
| New Positions | 10 | New | 69,505 | New |
| Sold Out Positions | 5 | Sold Out | 5,138 | Sold Out |
| Total Postitions | 44 | +10% | 714,177 | -16.81% |
| Vanguard Group Inc | $1,507.00 | 3.66% | 292,563 | +109,352 | +59.69% | 2025-09-30 |
| Commonwealth Equity Services, Llc | $902.00 | 2.19% | 175,209 | +175,209 | New | 2025-09-30 |
| Blackrock, Inc. | $701.00 | 1.7% | 136,087 | +21,842 | +19.12% | 2025-09-30 |
| Mai Capital Management | $396.00 | 0.96% | 76,861 | +11,928 | +18.37% | 2025-09-30 |
| Geode Capital Management, Llc | $313.00 | 0.76% | 60,751 | +34,833 | +134.4% | 2025-09-30 |
| Bank Of America Corp /De/ | $211.00 | 0.51% | 40,978 | -3 | <0.01% | 2025-09-30 |
| State Street Corp | $120.00 | 0.29% | 23,270 | +23,270 | New | 2025-09-30 |
| Osaic Holdings, Inc. | $89.00 | 0.22% | 17,323 | +1,793 | +11.54% | 2025-09-30 |
| Ubs Group Ag | $80.00 | 0.19% | 15,524 | -14,293 | -47.94% | 2025-09-30 |
| Northern Trust Corp | $73.00 | 0.18% | 14,205 | +14,205 | New | 2025-09-30 |